Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 3, 2014, Pages 236-242

  Huang, J W ^a   Lien, Y C ^b   Yang, C Y ^a   Liu, K L ^a   Wu, C F ^a   Yen, C J ^a   Wu, C K ^a   Lee, J K ^c   Ho, S R ^a   Wu, H Y ^a,c   Chiang, C K ^a   Cheng, H T ^d   Shyu, R S ^e   Hung, K Y ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI TZU CHI HOSPITAL   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e MIN SHENG GENERAL HOSPITAL   (Taiwan)

Author keywords

Abdominal aortic calcification; C reactive protein; Computed tomography; Fetuin A; Osteoprotegerin; Peritoneal dialysis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FETUIN A; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OSTEOPROTEGERIN;

ABDOMINAL AORTA; ADULT; AGE; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTERY CALCIFICATION; ARTICLE; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; DIABETIC PATIENT; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SURVIVAL PREDICTION; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ABDOMINAL AORTIC CALCIFICATION; C-REACTIVE PROTEIN; COMPUTED TOMOGRAPHY; FETUIN-A; OSTEOPROTEGERIN; PERITONEAL DIALYSIS;

ADULT; AGED; AORTA, ABDOMINAL; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCINOSIS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES; TAIWAN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84895808008     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.08.006     Document Type: Article

References (30)

1. Szeto C.C., Wong T.Y., Chow K.M., Leung C.B., Li P.K. Are peritoneal dialysis patients with and without residual renal function equivalent for survival study? Insight from a retrospective review of the cause of death. Nephrol Dial Transplant 2003, 18(5):977-982.
2. Goodman W.G., Goldin J., Kuizon B.D., Yoon C., Gales B., Sider D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000, 342(20):1478-1483.
3. Raggi P., Boulay A., Chasan-Taber S., Amin N., Dillon M., Burke S.K., et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?. J Am Coll Cardiol 2002, 39(4):695-701.
4. Giachelli C.M. Mechanisms of vascular calcification in uremia. Semin Nephrol 2004, 24(5):401-402.
5. Dellegrottaglie S., Sanz J., Rajagopalan S. Vascular calcification in patients with chronic kidney disease. Blood Purif 2006, 24(1):56-62.
6. Chen HY, Chiu YL, Chuang YF, Hsu SP, Pai MF, Lai CF, et al. Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis. Am J Kidney Dis 56(4):720-7.
7. Wang A.Y., Woo J., Lam C.W., Wang M., Chan I.H., Gao P., et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005, 20(8):1676-1685.
8. Kaden J.J., Bickelhaupt S., Grobholz R., Haase K.K., Sarikoc A., Kilic R., et al. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol 2004, 36(1):57-66.
9. Nitta K., Akiba T., Uchida K., Otsubo S., Takei T., Yumura W., et al. Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients. Nephrol Dial Transplant 2004, 19(7):1886-1889.
10. Okuno S., Ishimura E., Kitatani K., Fujino Y., Kohno K., Maeno Y., et al. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis 2007, 49(3):417-425.
11. Verbeke F, Van Biesen W, Honkanen E, Wikstrom B, Jensen PB, Krzesinski JM, et al. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol 6(1):153-9.
12. Miwa Y., Tsushima M., Arima H., Kawano Y., Sasaguri T. Pulse pressure is an independent predictor for the progression of aortic wall calcification in patients with controlled hyperlipidemia. Hypertension 2004, 43(3):536-540.
13. Wu HY, Hung KY, Huang TM, Hu FC, Peng YS, Huang JW, et al. Safety issues of long-term glucose load in patients on peritoneal dialysis - a 7-year cohort study. PloS One 7(1):e30337.
14. Wu H.Y., Hung K.Y., Huang J.W., Chen Y.M., Tsai T.J., Wu K.D. Initial glucose load predicts technique survival in patients on chronic peritoneal dialysis. Am J Nephrol 2008, 28(5):765-771.
15. Wu HY, Hung KY, Hu FC, Chen YM, Chu TS, Huang JW, et al. Risk factors for high dialysate glucose use in PD patients - a retrospective 5-year cohort study. Perit Dial Int 30(4):448-55.
16. Dobiasova M., Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem 2001, 34(7):583-588.
17. Odamaki M., Furuya R., Ohkawa S., Yoneyama T., Nishikino M., Hishida A., et al. Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol Dial Transplant 1999, 14(10):2427-2432.
18. Kiechl S., Schett G., Wenning G., Redlich K., Oberhollenzer M., Mayr A., et al. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 2004, 109(18):2175-2180.
19. Kazama J.J., Shigematsu T., Yano K., Tsuda E., Miura M., Iwasaki Y., et al. Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure. Am J Kidney Dis 2002, 39(3):525-532.
20. Nitta K., Akiba T., Uchida K., Kawashima A., Yumura W., Kabaya T., et al. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis 2003, 42(2):303-309.
21. Koo HM, Do HM, Kim EJ, Lee MJ, Shin DH, Kim SJ, et al. Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients. Atherosclerosis 219(2):925-30.
22. Ketteler M., Bongartz P., Westenfeld R., Wildberger J.E., Mahnken A.H., Bohm R., et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003, 361(9360):827-833.
23. Hamano T, Matsui I, Mikami S, Tomida K, Fujii N, Imai E, et al. Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol 21(11):1998-2007.
24. Tamashiro M., Iseki K., Sunagawa O., Inoue T., Higa S., Afuso H., et al. Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 2001, 38(1):64-69.
25. Li J.J., Zhu C.G., Yu B., Liu Y.X., Yu M.Y. The role of inflammation in coronary artery calcification. Ageing Res Rev 2007, 6(4):263-270.
26. Shao J.S., Cheng S.L., Sadhu J., Towler D.A. Inflammation and the osteogenic regulation of vascular calcification: a review and perspective. Hypertension 2010, 55(3):579-592.
27. Lee S.Y., Chen Y.C., Tsai I.C., Yen C.J., Chueh S.N., Chuang H.F., et al. Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients. PloS One 2013, 8(3):e57762.
28. Wang C.C., Sorribas V., Sharma G., Levi M., Draznin B. Insulin attenuates vascular smooth muscle calcification but increases vascular smooth muscle cell phosphate transport. Atherosclerosis 2007, 195(1):e65-75.
29. Cheng S.C., Chu T.S., Huang K.Y., Chen Y.M., Chang W.K., Tsai T.J., et al. Association of hypertriglyceridemia and insulin resistance in uremic patients undergoing CAPD. Perit Dial Int 2001, 21(3):282-289.
30. Kidney disease: improving global outcomes CKDMBDWG: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009, (113):S1-S130.